COMBIVENT

This brand name is authorized in Austria, Canada, Ecuador, Hong Kong, Mexico, Netherlands, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug COMBIVENT contains a combination of these active pharmaceutical ingredients (APIs):

1 Ipratropium
UNII J697UZ2A9J - IPRATROPIUM BROMIDE

Ipratropium is a quaternary ammonium compound with anticholinergic (parasympatholytic) properties. Ipratropium appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++, which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. Ca++ release is mediated by the second messenger system consisting of IP3 (inositol triphosphate) and DAG (diacylglycerol).

Read about Ipratropium
2 Salbutamol
UNII 021SEF3731 - ALBUTEROL SULFATE

Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases.

Read about Salbutamol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
COMBIVENT RESPIMAT Inhalation spray FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03AL02 Salbutamol and ipratropium bromide R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02419106
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29859-06-11
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 195416, 198695, 34064, 373645, 376257
Country: HK Department of Health Drug Office Identifier(s): 41964
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 261M97
Country: NL Z-Index G-Standaard Identifier(s): 14172348
Country: NL Z-Index G-Standaard, PRK Identifier(s): 81760
Country: SG Health Sciences Authority Identifier(s): 09558P
Country: US FDA, National Drug Code Identifier(s): 0597-0024
Country: ZA Health Products Regulatory Authority Identifier(s): 30/10.2.1/0476

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.